JAKi	Janus Kinase Inhibitors
s-JAKi	systemic Janus Kinase Inhibitor
t-JAKi	topical Janus Kinase Inhibitor
STAT	signal transducer and activator of transcription
AA	Alopecia Areata
AD	Atopic Dermatitis
AE	Adverse Event
PP	Plaque Psoriasis
FDA	Food and Drug Administration
TYK	Tyrosine Kinase
MACE	major cardiovascular events
VTE	venous thromboembolisms
RA	rheumatoid arthritis
NMSC	nonmelanoma skin cancers
CHE	chronic hand eczema
GVHD	graft-versus-host-disease
cGVHD	chronic graft-versus-host-disease
BSA	body surface area
Css	steady-state concentration
IGA	Investigator’s Global Assessment
MF	Myelofibrosis
EASI	Eczema Area and Severity Index
Cmax	maximum plasma concentration
AUC	area under the curve
EMA	European Medicines Agency
Tmax	time to maximum concentration
n/a	not applicable
CPK	creatine phosphokinase